For more than 75 years, Charles River has delivered solutions to accelerate the development of drugs, chemicals, and medical devices for the people and patients who need them. Our products and services support clients from basic research, discovery, and safety assessment, to manufacturing and commercialization. With this expansive end-to-end portfolio, global capacity, and proven scientific and regulatory advisors, our integrated approach enables maximum speed and confidence on the drive to market.
With over 40,000 tests run annually at our global biologics testing facilities and 200+ products supported. These include monoclonal antibodies/recombinant proteins, viral vectors, vaccines, and cell therapies.